CALVIRI INC — Form D/A
CALVIRI INC of PHOENIX, AZ, a company, filed a Form D amendment with the SEC on 2023-05-09. The offering totals $11.1M, of which $11.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-05-09
- Form: D/A
- Accession: 0001763612-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.1M
- Amount sold: $11.1M
- Remaining: $292
- Minimum investment: $25K
- Investors: 32
- Date of first sale: 2021-10-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-420935
Issuer
- Name: CALVIRI INC
- CIK: 0001763612
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 850 N 5TH ST., PHOENIX, AZ, 85004
- Phone: (480) 205-6436
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jeff J Le Benger | Director | Phoenix, AZ |
| Kathryn Albert Sykes | Director | Phoenix, AZ |
| Jeffrey J Le Benger | Director | Phoenix, AZ |
| Michael J McCallister | Director | Phoenix, AZ |
| Stephen Albert Johnston | Director | Phoenix, AZ |
| Stephen Albert Johnston | Executive Officer | Phoenix, AZ |
| Jacque J Sokolov | Director | New York, NY |
| Michael J Chambers | Director | Phoenix, AZ |
| Marc J Wolff | Director | Phoenix, AZ |
| Marc J Wolff | Executive Officer | Phoenix, AZ |
| George Albert Poste | Director | Tempe, AZ |
| Neal Albert Woodbury | Director | Tempe, AZ |
| Anna Albert Barker | Director | Tempe, AZ |
Other filings by this issuer (8)
More